홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Lithium Hydroxide → 2-((3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-((S)-1-(trifluoromethylsulfonamido)butan-2-yl)piperidin-3-yl)acetic acid

HRID 932135
노트
인쇄 미리보기

반응식

HRID 932135 반응식
ClC1C=C([C@@H]2[C@@H](C3C=CC(Cl)=CC=3)N([C@@H](CC)CO)C(=O)[C@](CC(OC)=O)(C)C2)C=CC=1.C(P(CCCC)(CCCC)=CC#N)CCC.FC(F)(F)S(N)(=O)=O.[Cl:57][C:58]1[CH:59]=[C:60]([C@@H:64]2[C@@H:69]([C:70]3[CH:75]=[CH:74][C:73]([Cl:76])=[CH:72][CH:71]=3)[N:68]([C@@H:77]([CH2:87][CH3:88])[CH2:78][NH:79][S:80]([C:83]([F:86])([F:85])[F:84])(=[O:82])=[O:81])[C:67](=[O:89])[C@:66]([CH2:91][C:92]([O:94]C)=[O:93])([CH3:90])[CH2:65]2)[CH:61]=[CH:62][CH:63]=1.[Li+].[OH-]>C1(C)C=CC=CC=1.C(O)C>[Cl:57][C:58]1[CH:59]=[C:60]([C@@H:64]2[C@@H:69]([C:70]3[CH:71]=[CH:72][C:73]([Cl:76])=[CH:74][CH:75]=3)[N:68]([C@@H:77]([CH2:87][CH3:88])[CH2:78][NH:79][S:80]([C:83]([F:86])([F:85])[F:84])(=[O:82])=[O:81])[C:67](=[O:89])[C@:66]([CH2:91][C:92]([OH:94])=[O:93])([CH3:90])[CH2:65]2)[CH:61]=[CH:62][CH:63]=1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 3939Lithium HydroxideHCID 79001TrifluoromethylsulfonamideHCID 4622928CyanomethylenetributylphosphoraneHCID 58573771Methyl 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-hydroxybutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetateHCID 67998602methyl 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-((S)-1-(trifluoromethylsulfonamido)butan-2-yl)piperidin-3-yl)acetate

생성물 1

HCID 585732772-((3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-((S)-1-(trifluoromethylsulfonamido)butan-2-yl)piperidin-3-yl)acetic acid

시약·촉매·용매 2

HCID 702Ethanol용매HCID 1140Toluene용매

반응 조건

온도
110 °C

실험 절차

A reaction vial under argon was charged with methyl 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-hydroxybutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetate (0.048 g, 0.1 mmol; Example 186, Step A), 2-(tributylphosphoranylidene) acetonitrile (0.036 g, 0.15 mmol) and trifluoromethanesulfonamide (0.022 g, 0.15 mmol) in toluene (0.5 mL). The reaction mixture in the reaction vial was sealed and stirred at 110° C. for 1 h. Column chromatography on silica gel gave a mixture of methyl 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-((S)-1-(trifluoromethylsulfonamido)butan-2-yl)piperidin-3-yl)acetate with an unknown impurity. This mixture was hydrolyzed with LiOH (1N solution in water, 0.3 mL) in ethanol (0.5 mL) for 3 h at rt. HPLC purification (C18 column, eluted with 10 to 95% CH3CN in water, with 0.1% TFA) gave the title compound.

후처리

  1. customA reaction vial under argon
  2. customThe reaction mixture in the reaction
  3. customvial was sealed
  4. customColumn chromatography on silica gel gave
  5. customHPLC purification (C18 column, eluted with 10 to 95% CH3CN in water, with 0.1% TFA)

출처 및 근거

ORD 기록
ord-4880c17012494804a3e9ec99136beb5d
출처 데이터셋
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09296736B2

반응 노트

불러오는 중…

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트